About Us   Technology   Media   Applications   Clinical Trials   Publications   News & Events   Investors  

Obsessive Compulsive Disorder - Double-Blind Placebo Control Safety and Feasibility Study

Sheba Medical Center, Tel Hashomer, Israel

1 June, 2011

A clinical trial in obsessive compulsive disorder (OCD) patients has begun at the Sheba Medical Center, Tel Hashomer, Israel.

 

The purpose of this study is to test whether the combination of Deep transcranial magnetic stimulation (Deep TMS) treatment with customary medication for OCD patients confers additional benefits over treatment that includes only medication.

 

30 OCD patients are expected to participate in the trial.

Related Links
Contact
User Login
Keep me signed in
Copyright 2009 @ Brainsway. Address: 19 Hartum st. Bynet Building, 1st floor, Har Hotzvim, Jerusalem, ISRAEL, zip code: 91451 Tel: 972-2-5813140, Fax: 972-2-5812517, Email: info@brainsway.com

Created by Catom.